Shaily Engineering Plastics Q3FY26: Revenue up 27% to ₹250.5 Cr, PAT up 48% to ₹37.4 Cr
Shaily Engineering Plastics reported Q3FY26 consolidated revenue of ₹250.5 crore (up 27%) and PAT of ₹37.4 crore (up 48%). For 9MFY26, revenue was ₹753.8 crore (up 32%) and PAT was ₹129.8 crore (up 101%). The company is setting up a medical device facility in Abu Dhabi with an investment of AED 130-150 million, operational by Q4 FY28. Mr. Joe Kam will join as COO (Healthcare) from March 1, 2026.
The substantial revenue and profit growth, coupled with strategic expansion plans like the Abu Dhabi facility and key management appointments, are likely to have a significant positive impact on investor perception and the company's future performance.
The company reported strong year-on-year growth in revenue and a significant increase in profit after tax for both the quarter and nine-month periods. The expansion into Abu Dhabi and the appointment of a new COO also signal positive future growth prospects.
Shaily Engineering Plastics Limited has released its financial results for the third quarter and nine months ended December 31, 2025 (Q3FY26).
For the quarter ended December 31, 2025, the company reported a consolidated revenue of ₹250.5 crore, marking a significant 27% increase compared to ₹197.6 crore in the same period last year (Q3FY25). Profit After Tax (PAT) saw a substantial rise of 48%, reaching ₹37.4 crore from ₹25.2 crore in Q3FY25. EBITDA also grew by 43% to ₹66.4 crore from ₹46.3 crore. The company highlighted that the improved traction in the healthcare segment was the key driver for the overall growth.
For the nine months ended December 31, 2025 (9MFY26), consolidated revenue increased by 32% to ₹753.8 crore from ₹569.0 crore in 9MFY25. PAT more than doubled, growing by 101% to ₹129.8 crore from ₹64.5 crore in 9MFY25. EBITDA surged by 76% to ₹218.4 crore from ₹123.8 crore.
Standalone revenues for Q3FY26 were ₹236.4 crore, a 27% increase, with PAT growing by 96% to ₹35.6 crore. For 9MFY26, standalone revenue was ₹697.1 crore (up 30%), and PAT increased by 172% to ₹112.6 crore.
The company also announced the appointment of Mr. Joe Kam as the Chief Operating Officer (Healthcare), effective March 1, 2026. Furthermore, Shaily Engineering Plastics is setting up a new facility in Abu Dhabi for manufacturing medical devices, with an investment of AED 130-150 million, expected to be operational by Q4 FY28.
The investor presentation, shared on February 12, 2026, provides detailed financial highlights, business updates, and operational trends. The earnings call to discuss these results is scheduled for Friday, February 13, 2026, at 4:00 p.m.
What to do with a filing like this
Shaily Engineering Plastics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shaily Engineering Plastics Limited. Read the original for the full detail.